newsletter subscription
newsletter subscription
New Medical Imaging Innovation from CASIO. We have formed a medical-engineering collaboration that leverages its long history of ground-breaking image processing technology to generate innovations in the Dermoscopy procedures. Our device realizes the quick and easy way to capture high quality images of skin lesions. Come and try our product at the booth in ESPD2025!
Chiesi Global Rare Diseases is a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living with rare diseases. As a family business, Chiesi Group strives to create a world where it is common to have a therapy for all diseases and acts as a force for good, for society and the planet. The goal of the Global Rare Diseases unit is to ensure equal access so as many people as possible can experience their most fulfilling life. The unit collaborates with the rare disease community around the globe to bring voice to underserved people in the health care system. For more information visit www.chiesirarediseases.com.
Website: www.chiesirarediseases.com
Krystal Biotech, Inc. (NASDAQ: KRYS) is a commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs. VYJUVEK® is the Company’s first commercial product, the first-ever redosable gene therapy, and the first medicine approved by the FDA for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing a robust preclinical and clinical pipeline of investigational genetic medicines in respiratory, oncology, dermatology, ophthalmology, and aesthetics. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania.
Website: www.krystalbio.com
At Phlecs, we believe UV-free blue LED light is an effective tool to help physicians and patients control the symptoms of itching and inflammatory skin conditions in a safe, fast and cost-effective manner. A recently published clinical trial shows that the Phlecs Full Body Blue Device can significantly improve the condition of patients with atopic dermatitis by substantially reducing pruritus and other symptoms, while also enhancing their quality of life — all after just 10 treatments. A new study combining blue light therapy with balneotherapy has shown even greater results in just two weeks. With the EU ban on UV fluorescent lamps set for February 2027, the Phlecs Full Body Blue Device offers an attractive alternative to traditional UV phototherapy.
Website: https://www.phlecs.com
Pierre Fabre is a leading global healthcare company, committed to improving the lives of patients through innovative solutions in dermatology and pediatrics. With over 50 years of expertise, we focus on developing high-quality, safe, and effective products tailored to the unique needs of children's skin. Our dedication to research and sustainability drives us to create dermatological treatments that prioritize both efficacy and environmental responsibility. At Pierre Fabre, we believe in nurturing healthy skin from the earliest stages of life, ensuring that every child receives the gentle care they deserve. Join us in advancing pediatric dermatology for a healthier future.
Website: https://www.pierre-fabre.com/en
Website: http://www.ceramol.com/
Viatris Inc. is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. From cardiovascular health to dermatology, Viatris offers quality treatment options across more than 10 major therapeutic areas, covering a wide variety of noncommunicable and infectious diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India.
Website : viatris.com,
Twitter : https://x.com/ViatrisInc
LinkedIn : https://www.linkedin.com/company/viatris/
Instagram : https://www.instagram.com/viatrisinc
YouTube : https://www.youtube.com/c/Viatris
Address for official postal correspondence:
ESPD Office
c/o C-IN
5. kvetna 65, Prague Congress Centre
140 21 Prague 4
Czech Republic
Registered at:
1 Place de l'Hôpital
670 91 Strasbourg CEDEX
France
Office email address
office@espd.info
Copyright © 2022 European Society for Pediatric Dermatology
Powered by APPTIDE | Created by C-IN | Privacy Policy